Bowen Matthew bought GLUE
April 6, 2026 · Form 4 insider transaction
Bowen Matthew bought 19,500 shares of Monte Rosa Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
19,500
Price
$0.00
Total value
N/A
InsiderBowen Matthew
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateApril 6, 2026
Filing dateApril 7, 2026
Shares owned after19,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of this option shall vest and become exercisable on April 6, 2027, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.